Is your drug Phase II ready?
The entire process of moving a drug from design to clinical trials takes 10 to 12 years on average. The drug development process must navigate through several stages in order to produce a product that is safe, efficacious, and has passed all regulatory requirements. From inception of IDEA to imminent EXIT strategy, VJO Canada will customize the complete research process by optimizing performance output and ensuring completion of tasks.
Stop by and meet our subject matter/ board certified experts at Booth #203 - to explore how we can optimize strategy for your drug development platforms and accelerate your path towards an imminent “Phase 2 – Ready” drug.
Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Appointment Request
Blocked Timeslot
Restricted Timeslot
Copyright © 2022 American College of Toxicology. All rights reserved.
You may view the ACT Privacy Policy, Code of Conduct, provide consent to ACT to email you communications, or unsubscribe to stop receiving further ACT communication.
Privacy Policy | Code of Conduct | Provide Consent | Unsubscribe